Ledger.Open graph →
SEC Form D · filed August 1, 2017

Indalo Therapeutics, Inc

Offering
$26.0M
Sold
$9.0M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
ST. LOUIS, MO
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (6)

Bradford H. Williamson · St. Louis, MOExecBen H. Auspitz · St. Louis, MODirectorScott H. Seiwert · St. Louis, MOExecPeter H. Barrett · St. Louis, MODirectorGeorge H. Capps Ii · St. Louis, MOExec · PromoterRajesh H. Devraj · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗